Specimen: 3 mL (2.5 mL min.) Plasma from 1 Lavender Top (EDTA) tube. Patient should be ambulatory / upright 2 hours prior to the test. Separate plasma and freeze. Ship frozen. DO NOT THAW. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician.
Stability (Room): N/A
Stability (Refrigerated): N/A
Stability (Frozen): 4 weeks
Method: CLIA
Comment:
Price: Contact Medilab
Turnaround time (TAT): 7 – 15 dyas
Usage: This ratio can be used as a screening test in cases of severe hypertension. The ratio allows detection of cases of Primary Aldosteronism in normokalemic patients.
Specialty: Endocrinologist
Disease: Disorders of Adrenal Gland
Components:
Courier Charges:
Home Collection: Not Available
Department:
Pre-test Information: Patient should be ambulatory / upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician.
